Cart
Account
Your Orders
Sign In
Meet the Team Advancing CRISPR
Synthego is a pioneering force in the biotechnology industry, dedicated to advancing the frontiers of CRISPR cell and gene therapies through cutting-edge CRISPR technology and expertise.
Synthego offers a continuum of best-in-class solutions designed for advancing CRISPR-based therapeutics.
Accelerating CRISPR-based cell and gene therapy with pioneering solutions
Synthego is a pioneering force in the biotechnology industry, dedicated to advancing the frontiers of CRISPR cell and gene therapies through cutting-edge CRISPR technology and expertise.
This robust RNA polymerase, derived from the T7 bacteriophage, transcribes RNA from DNA sequences under the control of the T7 promoter.
Protect RNA stability and purity, from research to therapeutic development.
Bringing high fidelity and affordability to your breakthrough cell & gene therapy.
Proven GMP-grade SpCas9 nuclease for your CRISPR-based therapeutics.
Early discovery breakthroughs in therapeutic development begin with research single guide RNA (sgRNA).
Reliable GMP-grade sgRNA for your CRISPR-based therapeutics.
Curious about base editing but not sure where to begin? We’ll break it down step by step, making it easy to follow and apply!
The CRISPR gene therapy regulatory space is changing rapidly. In this blog, we’re covering the latest cell and gene therapy news, including updated FDA guidances.
New CRISPR therapies are undergoing development for genetic disorders, cancer, and infectious diseases, at all stages of the clinical workflow. We know it can be tough to keep up with...